CAS: 1382979-44-3
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | 2-Pyrimidinamine, 5-[8,9-dihydro-6,6-dimethyl-4-(4-morpholinyl)-6H-[1,4]oxazino[4,3-e]purin-2-yl]- REF: IN-DA0018GRCAS: 1382979-44-3 | 95% | A consultar | Mar 07 Ene 25 |
 | GDC0084 REF: TM-T3705CAS: 1382979-44-3 | 99.16% - ≥95% | 35,00 €~1.104,00 € | Mar 14 Ene 25 |
 | GDC 0084 REF: 3D-FD145121CAS: 1382979-44-3 | Min. 95% | A consultar | Mar 18 Feb 25 |
![2-Pyrimidinamine, 5-[8,9-dihydro-6,6-dimethyl-4-(4-morpholinyl)-6H-[1,4]oxazino[4,3-e]purin-2-yl]-](https://static.cymitquimica.com/products/IN/thumb/DA0018GR.jpg)
2-Pyrimidinamine, 5-[8,9-dihydro-6,6-dimethyl-4-(4-morpholinyl)-6H-[1,4]oxazino[4,3-e]purin-2-yl]-
CAS:1382979-44-3
Fórmula:
C18H22N8O2
Pureza:
95%
Forma y color:
Solid
Peso molecular:
382.4197
Ref: IN-DA0018GR
| 5mg | 50,00 € | ||
| 10mg | 65,00 € | ||
| 25mg | 103,00 € | ||
| 50mg | 171,00 € | ||
| 100mg | 208,00 € | ||
| 250mg | 468,00 € |
Entrega estimada en Estados Unidos, el Martes 7 de Enero de 2025
GDC0084
CAS:1382979-44-3
GDC0084 (RG7666) is a PI3K inhibitor with potential antineoplastic activity.
Fórmula:
C18H22N8O2
Pureza:
99.16% - ≥95%
Forma y color:
Solid
Peso molecular:
382.42
Ref: TM-T3705
| 2mg | 42,00 € | ||
| 5mg | 60,00 € | ||
| 10mg | 96,00 € | ||
| 25mg | 171,00 € | ||
| 50mg | 276,00 € | ||
| 100mg | 522,00 € |
Entrega estimada en Estados Unidos, el Martes 14 de Enero de 2025
GDC 0084
CAS:1382979-44-3
PI3K and mTOR enzyme inhibitor; anti-cancer agent
Fórmula:
C18H22N8O2
Pureza:
Min. 95%
Peso molecular:
382.42 g/mol
Ref: 3D-FD145121
| 1mg | A consultar | ||
| 2mg | A consultar | ||
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 18 de Febrero de 2025
